Compare MDWD & XPOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MDWD | XPOF |
|---|---|---|
| Founded | 2000 | 2017 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 224.6M | 289.4M |
| IPO Year | 2013 | 2021 |
| Metric | MDWD | XPOF |
|---|---|---|
| Price | $17.42 | $4.56 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 8 |
| Target Price | ★ $37.50 | $10.31 |
| AVG Volume (30 Days) | 74.6K | ★ 635.2K |
| Earning Date | 01-01-0001 | 05-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $13,987,000.00 |
| Revenue This Year | $6.97 | N/A |
| Revenue Next Year | $23.59 | $13.55 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 4.40 |
| 52 Week Low | $14.14 | $4.06 |
| 52 Week High | $22.51 | $13.74 |
| Indicator | MDWD | XPOF |
|---|---|---|
| Relative Strength Index (RSI) | 48.71 | 22.01 |
| Support Level | $17.50 | N/A |
| Resistance Level | $18.58 | $9.25 |
| Average True Range (ATR) | 0.58 | 0.53 |
| MACD | 0.01 | -0.41 |
| Stochastic Oscillator | 42.66 | 15.61 |
MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.
Xponential Fitness Inc is a curator of boutique fitness brands. Its diversified portfolio of brands includes Club Pilates, a Pilates brand in the United States; CycleBar, an indoor cycling brand in the United States; StretchLab, a concept offering one-on-one and group stretching services; Row House, a high-energy, low-impact indoor rowing workout; AKT, a dance-based cardio workout combining toning, interval and circuit training; YogaSix a franchised yoga brand; Pure Barre, a total body workout that uses the ballet barre to perform small isometric movements; Stride, a treadmill-based cardio and strength training concept; Rumble, a boxing-inspired full-body workout; and BFT, a functional training and strength-based program. Its key revenue source is franchise income.